219 studies found for:    treatment experienced OR treatment failure OR second line OR resistance OR salvage therapy | Open Studies | HIV
Show Display Options
Rank Status Study
21 Unknown  Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma
Conditions: HIV;   Lymphoma
Intervention:
22 Unknown  EARNEST Rifabutin Pharmacokinetics (PK) Substudy
Conditions: HIV;   Tuberculosis
Intervention: Drug: Rifabutin
23 Unknown  High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease
Conditions: HIV;   AIDS
Intervention: Drug: Kaletra (drug)
24 Unknown  Pediatric Nevirapine Resistance Study
Conditions: AIDS;   HIV Infections
Intervention: Drug: nevirapine
25 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: PEG-IFNa 2a;   Drug: Ribavirin;   Drug: NUCS
26 Recruiting Efficacy and Safety Study of Darunavir for the Treatment of HIV/AIDS
Condition: HIV/AIDS
Interventions: Drug: Darunavir;   Drug: ART with 2 NRTIs plus LPV/r (or ATV/r)
27 Recruiting A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure
Condition: HIV-1 Infection
Interventions: Drug: Darunavir;   Drug: Etravirine;   Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Raltegravir;   Drug: Second line ART regimens are usually based on a boosted protease inhibitor (bPI) plus two nucleoside analogues (NRTIs);   Drug: Study provided drugs according to patient resistance profile (DRV, ETR, RTV, FTC/TDF) + any in country available drug as applicable & available;   Other: SOC adherence versus SOC+CPI adherence
28 Unknown  Evaluation of Use of Clinical Decision Support System in HIV Care in Resource Constrained Settings
Condition: HIV
Interventions: Other: EMR Only;   Other: EMR+CDSS
29 Recruiting The VMVN Study: Virological Monitoring in Viet Nam
Conditions: HIV Infection;   AIDS
Interventions: Other: Standard Care;   Other: Virological Monitoring
30 Recruiting National Evaluation of PI-based 2nd Line Efficacy in Cambodia
Condition: HIV
Intervention:
31 Unknown  Dolutegravir Expanded Access Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: dolutegravir
32 Recruiting Kumasi Cohort Study
Condition: HIV
Intervention: Other: Virological monitoring
33 Not yet recruiting Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum
Conditions: Malaria in Pregnancy;   HIV Infection
Interventions: Drug: cotrimoxazole daily prophylaxis;   Drug: sulphadoxine-pyrimethamine
34 Recruiting Third Line Antiretroviral Threatment Optimization in Sub-Saharan Africa
Condition: HIV Infection
Interventions: Behavioral: adherence reinforcement;   Drug: Antiretroviral Therapy Darunavir/r + Raltegravir + 2 NRTIs (as chosen by the investigators)
35 Recruiting International HIV Antiretroviral Adherence, Resistance and Survival
Condition: HIV/AIDS
Intervention:
36 Unknown  Resistance to HIV Infection
Condition: HIV Infections
Intervention:
37 Not yet recruiting Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: DTG 50 mg;   Drug: EFV 600 mg
38 Recruiting Tauroursodeoxycholic Acid for Protease-inhibitor Associated Insulin Resistance
Conditions: HIV Related Insulin Resistance;   Protease Inhibitor Related Insulin Resistance;   Endoplasmic Reticulum Stress
Intervention: Drug: Tauroursodeoxycholic acid
39 Recruiting Seroconversions, Resistance, Adverse Events and Drug Adherence Among Subjects Taking Truvada® for PrEP: A Case Control Study
Condition: HIV
Intervention:
40 Not yet recruiting Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection
Conditions: Viral Hepatitis C;   HIV
Intervention: Drug: Sofosbuvir/Ledipasvir fixed dose

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years